198 related articles for article (PubMed ID: 33132845)
1. Comparison of CRISPR/Cas Endonucleases for
Li F; Wing K; Wang JH; Luu CD; Bender JA; Chen J; Wang Q; Lu Q; Nguyen Tran MT; Young KM; Wong RCB; Pébay A; Cook AL; Hung SSC; Liu GS; Hewitt AW
Front Cell Neurosci; 2020; 14():570917. PubMed ID: 33132845
[TBL] [Abstract][Full Text] [Related]
2. AAV-Mediated CRISPR/Cas Gene Editing of Retinal Cells In Vivo.
Hung SS; Chrysostomou V; Li F; Lim JK; Wang JH; Powell JE; Tu L; Daniszewski M; Lo C; Wong RC; Crowston JG; Pébay A; King AE; Bui BV; Liu GS; Hewitt AW
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3470-6. PubMed ID: 27367513
[TBL] [Abstract][Full Text] [Related]
3. Utility of Self-Destructing CRISPR/Cas Constructs for Targeted Gene Editing in the Retina.
Li F; Hung SSC; Mohd Khalid MKN; Wang JH; Chrysostomou V; Wong VHY; Singh V; Wing K; Tu L; Bender JA; Pébay A; King AE; Cook AL; Wong RCB; Bui BV; Hewitt AW; Liu GS
Hum Gene Ther; 2019 Nov; 30(11):1349-1360. PubMed ID: 31373227
[TBL] [Abstract][Full Text] [Related]
4. Adeno-Associated Vector-Delivered CRISPR/
Helfer-Hungerbuehler AK; Shah J; Meili T; Boenzli E; Li P; Hofmann-Lehmann R
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452500
[TBL] [Abstract][Full Text] [Related]
5. Factors Impacting Efficacy of AAV-Mediated CRISPR-Based Genome Editing for Treatment of Choroidal Neovascularization.
Chung SH; Mollhoff IN; Nguyen U; Nguyen A; Stucka N; Tieu E; Manna S; Meleppat RK; Zhang P; Nguyen EL; Fong J; Zawadzki R; Yiu G
Mol Ther Methods Clin Dev; 2020 Jun; 17():409-417. PubMed ID: 32128346
[TBL] [Abstract][Full Text] [Related]
6. Divergent susceptibilities to AAV-SaCas9-gRNA vector-mediated genome-editing in a single-cell-derived cell population.
Morsy SG; Tonne JM; Zhu Y; Lu B; Budzik K; Krempski JW; Ali SA; El-Feky MA; Ikeda Y
BMC Res Notes; 2017 Dec; 10(1):720. PubMed ID: 29221488
[TBL] [Abstract][Full Text] [Related]
7. CRISPR Systems Suitable for Single AAV Vector Delivery.
Stevanovic M; Piotter E; McClements ME; MacLaren RE
Curr Gene Ther; 2022; 22(1):1-14. PubMed ID: 34620062
[TBL] [Abstract][Full Text] [Related]
8. Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.
Hung SS; Li F; Wang JH; King AE; Bui BV; Liu GS; Hewitt AW
Methods Mol Biol; 2018; 1715():113-133. PubMed ID: 29188510
[TBL] [Abstract][Full Text] [Related]
9. Two high-fidelity variants: efSaCas9 and SaCas9-HF, which one is better?
Lv J; Xi H; Lv X; Zhou Y; Wang J; Chen H; Yan T; Jin J; Zhao J; Gu F; Song Z
Gene Ther; 2022 Aug; 29(7-8):458-463. PubMed ID: 35095097
[TBL] [Abstract][Full Text] [Related]
10. The Development of an AAV-Based CRISPR SaCas9 Genome Editing System That Can Be Delivered to Neurons
Kumar N; Stanford W; de Solis C; Aradhana ; Abraham ND; Dao TJ; Thaseen S; Sairavi A; Gonzalez CU; Ploski JE
Front Mol Neurosci; 2018; 11():413. PubMed ID: 30483052
[TBL] [Abstract][Full Text] [Related]
11. A consolidated AAV system for single-cut CRISPR correction of a common Duchenne muscular dystrophy mutation.
Zhang Y; Nishiyama T; Li H; Huang J; Atmanli A; Sanchez-Ortiz E; Wang Z; Mireault AA; Mammen PPA; Bassel-Duby R; Olson EN
Mol Ther Methods Clin Dev; 2021 Sep; 22():122-132. PubMed ID: 34485599
[TBL] [Abstract][Full Text] [Related]
12. Optimized CRISPR/Cas9 system for gene knockout in chicken DF1 cells.
Zou K; Wang F; Zhang Z; Zhou Y; Li P; Wang D; Zhu M; Jia C; Wei Z
Poult Sci; 2023 Oct; 102(10):102970. PubMed ID: 37562129
[TBL] [Abstract][Full Text] [Related]
13. Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection.
Wang Q; Chen S; Xiao Q; Liu Z; Liu S; Hou P; Zhou L; Hou W; Ho W; Li C; Wu L; Guo D
Retrovirology; 2017 Nov; 14(1):51. PubMed ID: 29141633
[TBL] [Abstract][Full Text] [Related]
14. Simple-to-use CRISPR-SpCas9/SaCas9/AsCas12a vector series for genome editing in Saccharomyces cerevisiae.
Okada S; Doi G; Nakagawa S; Kusumoto E; Ito T
G3 (Bethesda); 2021 Dec; 11(12):. PubMed ID: 34739076
[TBL] [Abstract][Full Text] [Related]
15. Highly efficient heritable plant genome engineering using Cas9 orthologues from Streptococcus thermophilus and Staphylococcus aureus.
Steinert J; Schiml S; Fauser F; Puchta H
Plant J; 2015 Dec; 84(6):1295-305. PubMed ID: 26576927
[TBL] [Abstract][Full Text] [Related]
16. Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.
Soares Medeiros LC; South L; Peng D; Bustamante JM; Wang W; Bunkofske M; Perumal N; Sanchez-Valdez F; Tarleton RL
mBio; 2017 Nov; 8(6):. PubMed ID: 29114029
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic In Vivo Gene Editing Achieved by a Hypercompact CRISPR-Cas12f1 System Delivered with All-in-One Adeno-Associated Virus.
Cui T; Cai B; Tian Y; Liu X; Liang C; Gao Q; Li B; Ding Y; Li R; Zhou Q; Li W; Teng F
Adv Sci (Weinh); 2024 May; 11(19):e2308095. PubMed ID: 38408137
[TBL] [Abstract][Full Text] [Related]
18.
Li Q; Su J; Liu Y; Jin X; Zhong X; Mo L; Wang Q; Deng H; Yang Y
Mol Ther Methods Clin Dev; 2021 Mar; 20():652-659. PubMed ID: 33718515
[TBL] [Abstract][Full Text] [Related]
19. Improving CRISPR Gene Editing Efficiency by Proximal dCas9 Targeting.
Chen F; Ding X; Feng Y; Seebeck T; Jiang Y; Davis GD
Bio Protoc; 2017 Aug; 7(15):e2432. PubMed ID: 34541154
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice.
Ohmori T; Nagao Y; Mizukami H; Sakata A; Muramatsu SI; Ozawa K; Tominaga SI; Hanazono Y; Nishimura S; Nureki O; Sakata Y
Sci Rep; 2017 Jun; 7(1):4159. PubMed ID: 28646206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
